Many transgenic mouse models exist that mimic a range of Alzheimer’s disease (AD)—related pathologies. They play a key role in both basic research and preclinical testing of potential therapeutics for AD. Although they have contributed greatly to the pathophysiology of β-amyloid toxicity, none fully replicates the human disease.
Continue reading...
No comments:
Post a Comment